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Hippocampal pyramidal neurons of the CAl region express 5-
hydroxytryptamine (serotonin, 5-HI) receptors which, upon ac-
tivation, elicit a slow membrane depolarization and a decrease
in the calcium-activated afterhyperpolanzation present in these
cells. Previous electrophysiological studies have shown that this
receptor(s) exhibits a pharmacological profile similar to that of
the 5-HT1, 5-HI3 and 5-HT4 subtypes. In the present study,
intracellular recordings in rat brain slices were used in order to
examine the effects of a variety of compounds that distinguish
between these receptor subtypes. Administration of 5-HT in the
presence of a 5-HTIA receptor antagonist elicited a depolarization
and a concentration-dependent reduction in the amplitude of the
afterhyperpolanzation. These effects were mimicked by 5-meth-
oxytryptamine and 5-carboxyamidotryptamine but not by 2-
methyl-S-HI or phenylbiguanide. Administration of the benzam-
ides BRL 24924, zacopnde and cisapnde blocked the responses
to 5-HI with micromolar affinity although, in a small proportion
of the cells tested, BRL 24924 was found to exhibit some agonist
activity. This suggests that these compounds function as weak
partial agonists in the rat hippocampus. These results establish
clear differences between the 5-HI receptor(s) mediating the
depolarization and reduction in the afterhyperpolanzation in the
hippocampus and the 5-HT3 and 5-HT1 receptors and suggest
its classification in the 5-HT4 class. Thus, 5-HI4 receptors appear
capable of mediating slow excitatory responses to 5-HI in the
brain.
Numerous electrophysiological studies have examined the
slow excitatory actions of 5-HT in various regions of the central
and peripheral nervous system (for review, see Andrade and
Chaput, 1990). These studies have shown that slow membrane
depolarizations produced by 5-HT are generally mediated by a
decrease in resting potassium conductance (Vandermaelen and
Aghajanian, 1982; Andrade and Nicoll, 1987; Surprenant and
Crist, 1988; North and Uchimura, 1989), although slow depo-
larizations associated with an increased conductance have also
been described (Bobker and Williams, 1989; Pape and Mc-
Cormick, 1989). The 5-HT receptors which signal the depolar-
izations associated with a decreased membrane conductance
appear to represent a heterogenous group, which includes 5-
HT2 receptors (Davies et at., 1987; North and Uchimura, 1989;
Araneda and Andrade, 1991) and 5-HT receptors possessing a
pharmacological profile distinct from that of the presently
characterized 5-HT receptor subtypes (Andrade and Nicoll,
1987; Branchek et at., 1988; Connell and Wallis, 1989; Mawe et
at., 1989). Prominent within this class of atypical 5-HT recep-
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tors is that mediating the slow membrane depolarization and
reduction of the AHP present in rat hippocampus pyramidal
neurons (Andrade and Nicoll, 1987; Colino and Halliwell, 1987;
Beck, 1989; Chaput et at., 1990). These actions of 5-HT are not
altered by classical 5-HT1 and 5-HT2 receptor antagonists but
are selectively blocked by the substituted benzamide BRL
24924 and, to a lesser extent, by ICS 205-930 and metoclopram-
ide but not by other 5-HT3 receptor antagonists (Chaput et at.,
1990). In the present study we report on a series of experiments
aimed at further characterizing the pharmacology of this recep-
tor.
Methods
Preparation and maintenance of brain slices. Preparation and
maintenance of brain slices were as described previously (Nicoll and
Alger, 1981; Andrade et al., 1986). Briefly, male Sprague-Dawley rats
(150-300 g) were anesthetized with halothane and decapitated using a
small animal guillotine. The brain was removed rapidly and immersed
for 1 to 2 mm in ice-cold Ringer’s solution of standard composition (in
millimolar: NaC1, 119; KC1, 2.5; MgSO4 . 7H20, 1.3; CaCl2, 2.5; Na-
H2P04, 1; NaHCO3, 26.2; and dextrose, 11). Both hippocampi were
dissected and slices (400 MM nominal thickness) were cut using a
manual tissue chopper. The slices were then placed in a static interface
chamber at room temperature under a moist atmosphere of 95% 02 for
at least 1 hr before the experiment. At the end of this period slices
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were transferred one at a time to a recording chamber. In this chamber
they were held submerged between two nylon nets and were perfused
continuously at a rate of approximately 1 to 2 ml/min with normal
Ringer’s solution saturated with 95% 02 and 5% CO2. The temperature
of the recording chamber was maintained at 30 ± 1’C.
Recordings from CA1 hippocampus pyramidal neurons. Intra-
cellular recording electrodes were pulled from omega-dot glass (1.2 mm
outside diameter, Glass Co. of America, Bargaintown, NJ) on a Flam-
ing-Brown type horizontal puller (model 80/PC, Sutter Instruments,
San Rafael, CA) and filled with 2 M KMeSO4 (ICN Pharmaceuticals,
Plainview, NY) to give resistances of 50 to 120 megohms. Pyramidal
neurons of the CA1 region were impaled by either passing a brief high
voltage pulse through the electrode or by increasing the capacity
compensation of the amplifier to cause the headstage to momentarily
oscillate. Signals were amplified using an AXOCLAMP hA amplifier
(Axon Instruments, Foster City, CA) and recorded on a Gould (Cleve-
land, OH) paper chart recorder (model RS 3400). Fast transient signals
which could not be resolved adequately by the paper chart recorder
were digitalized using a 12 bit A/D converter controlled by an Intel
80286-based microcomputer and stored to disk.
After impalement, cells were allowed to seal for approximately 20 to
25 mm while brief (70 msec), low frequency hyperpolarizing pulses
(0.15 Hz) were passed through the recording electrode. Initially, as
sealing occurred, cells hyperpolarized to -70 to -80 mV over several
mm after which they began a slow, gradual depolarization to a stable
membrane potential ofbetween -60 and -70 mV which generally could
be maintained for the duration of the impalement (up to several hr).
In most experiments cells were bathed in TTX (0.5 tM) and TEA (5
mM) to allow for the generation of calcium spikes. Under these con-
ditions a single, brief (70 msec) constant current pulse was delivered
through the recording electrode resulting in a regenerative calcium
spike (Madison and Nicoll, 1986; Andrade and Nicoll, 1987; Chaput et
a!., 1990) which, in turn, was followed by a large AHP. This procedure
was preferred to examining the AHP after a burst of spikes as the
constancy of the calcium spike as well as the large size and long term
stability of the accompanying AHP greatly facilitate the systematic
examination of the effects of 5-HT. In order that the slow excitatory
actions of 5-HT might be examined in relative isolation of the 5-HT1A-
mediated membrane hyperpolarization and increased conductance,
most experiments reported in this study were conducted in the presence
of BMY 7378 (Yocca et al., 1987) which effectively blocks the 5-HTIA
receptor-mediated hyperpolarization of CA1 hippocampus pyramidal
neurons without altering the excitatory actions of 5-HT on these cells
(Chaput et at., 1990). All chemicals were obtained from Sigma Chemical
Co. (St. Louis, MO) except for phenylbiguanide which was from Aldrich
Chemical Co. (Milwaukee, WI) and 2-methyl-5-HT, zacopride and 5-
carboxyamidotryptamine which were from Research Biochemicals Inc.
(Wayland, MA) BMY 7378 was a kind gift from Bristol-Myers (Evans-
vile, IN), BRL 24924 from Beecham (Betchworth, England) and cisa-
pride from Janssen Pharmaceutica (Beerse, Belgium).
Experimental design and data analysis. All drugs were admin-
istered dissolved at known concentrations in the bath. Concentration-
response curves for agonists were constructed in individual neurons by
bath administration of a series of concentrations, each administration
separated from the following by a wash of a duration sufficient for the
complete recovery ofthe response to control level. Dose-response curves
were fitted iteratively to a logistic equation using the Marquardt-
Levenberg algorithm to obtain maximum response and EC values. In
experiments aimed at assessing the potency of substituted benzamides,
PA2 values were calculated by determining equieffective concentrations
of 5-HT before and after a single concentration of the benzamide. The
second administration of 5-HT generally followed administration of
the benzamide by at least 30 mm as preliminary experiments indicated
that 20 to 40 mm were required for BRL 24924 or zacopride to reach
equilibrium (two cells tested for each). Inasmuch as previous studies
have shown that 5-HT uptake does not significantly distort the con-
centration-response curve for 5-HT in this preparation (Andrade and
Nicoll, 1987), reuptake blockers were not used in these experiments.
All statistical comparisons used t tests except when an agonist potency
was assessed before and after a manipulation in the same cell, in which
case a paired t test was used. Statistical comparison between variances
used an F distribution to test the hypothesis that the ratio of the
variances was equal to 1.
Results
As reported previously (Andrade and Nicoll, 1987; Colino
and Halliwell, 1987; Chaput et al., 1990), administration of 5-
HT to pyramidal neurons of the CA1 region of the rat hippo-
campus results in the activation of at least two distinct 5-HT
receptors. The most obvious effect is a membrane hyperpolar-
ization (fig. 1A1) which is mediated by the activation of a 5-
HT1A receptor. A second effect is a reduction of the AHP
present in CA1 neurons. This phenomenon is best observed in
relative isolation of the 5-HTA-mediated membrane hyperpo-
larization, as obtained after administration of BMY 7378 (fig.
1A2). This compound is a selective 5-HT1A ligand that functions
as an antagonist in this area (Chaput et at., 1990). Under these
conditions it is also possible to observe in isolation a 5-HT-
induced slow membrane depolarization which often accompa-
nies the reduction of the AHP (fig. 1A2).
In a first series of experiments, the concentration-range of
5-HT which effectively signals the reduction of the AHP was
compared to that which is effective in signaling the 5-HT1A-
mediated membrane hyperpolarization. Bath administration of
5-HT dose-dependently reduced the AHP in the range of 1 to
100 ,M. The maximal effect of 5-HT estimated in 10 cells in
which complete dose-responses were obtained was 58 ± 9% (n
= 10 cells), and the ECro for this response was 11 ± 6.4 tM (n
= 10 cells, fig. 1C). In a comparable group of cells the EC50 for
the 5-HT1A receptor-mediated hyperpolarization was found to
be 7.0 ± 0.6 tM (mean ± S.D., n = 5 cells, fig. 1B) and the
maximal hyperpolarization was 10.9 ± 2.8 mV (n = 5 cells,
mean ± S.D.). Interestingly, although the sensitivity of the
5HT1A hyperpolarizing response was very constant from cell to
cell (ECro range: 6.5 to 7.7 tM, see also Andrade et at., 1986;
Andrade and Nicoll, 1987), there was considerable variability
in the sensitivity of the AHP to 5-HT (ECro range: 3.7 to 27
M, fig. 1C). Indeed, the sensitivity (ECro) of the AHP to 5-
HT exhibited a significantly larger variance than the sensitivity
of the 5-HT1A response (P = .00013).
As illustrated in Figure 2A, bath administered 5-CT also
hyperpolarized the membrane of pyramidal neurons in a con-
centration-dependent manner in the range of 10 nM to 10 zM.
As expected for a 5-HT1A receptor-mediated response, 5-CT
was found to exhibit an intrinsic activity comparable to that of
5-HT but to be approximately one order of magnitude more
potent (ECro: 0.54 ± 0.42 zM, mean ± S.D., n = 3 cells). Unlike
5-HT, however, 5-CT could differentiate between the 5-HT1A
receptor and that mediating the reduction in the AHP. Thus,
when the 5-HT1A receptor-mediated hyperpolarization was
blocked, concentrations of 5-CT capable of submaximally ac-
tivating 5-HT1A receptors were without effect on the AHP.
Indeed, 5-CT began to reduce the AHP only at concentrations
that were near maximal for activation of 5-HT1A receptors (fig.
2, A and B). Unfortunately, the potency of 5-CT in reducing
the AHP could not be quantified as it was difficult to completely
inhibit the hyperpolarizing response at these high concentra-
tions. However, it would appear that 5-CT is at least several-
hundred fold less potent at reducing the AHP than at signaling
the 5-HTIA-mediated membrane hyperpolarization (fig. 2B). In
A 5-HT
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Fig. 1. Concentration-response relation-
ship for the effects of 5-HT in the CAl
region of the hippocampus. A, administra-
tion of 5-HT hyperpolarizes this pyramidal
neuron in a concentration-dependent
manner. A2, after administration of BMY
7378 (1 0 SM), 5-HT induces a decrease
in the amplitude of the AHP and a small
depolarization of the membrane potential.
A1 and A2 were obtained in the presence
of TTX (1 ,M) and TEA (5 mM) from the
same neuron. In A2 a depolarizing current
pulse capable of triggering a calcium
spike was delivered every 30 sec. The
calcium spike was followed by a large
AHP (downward deflections in A2). Traces
a, b and c, three selected AHPs plotted
using an expanded time scale to illustrate
the time course of this afterpotential. Cell
membrane potential, -69 mV. B, dose
responses for the 5-HT1A receptor me-
diate hyperpolarization in 5 neurons. Be-
cause two of these cells gave essentially
identical responses, a single fitted curve
was drawn for both of them. C, dose
response relationship for the 5-HT-in-
duced reduction in AHP amplitude for five
representative neurons.
contrast to these effects of 5-CT, 5-HT was approximately
equipotent at eliciting a hyperpolarizing response and reducing
the AHP when compared in single neurons (fig. 2C, n = 4
cells).
Relationship to the 5-HT1 and 5-HT3 receptors. We
have reported previously that the 5-HT receptor(s) which sig-
nals the reduction in AHP amplitude and membrane depolari-
zation exhibits a pharmacological profile similar to that of 5-
HT3, 5-HT1 and 5-HT4 receptors (Chaput et at., 1990). Phen-
ylbiguanide and 2-methyl-5-HT are effective 5-HT3 receptor
agonists (Hoyer and Neijt, 1988) and the latter has also been
reported to possess agonist activity at 5-HT1 receptors (Mawe
et at., 1986; Surprenant and Crist, 1988). It was therefore of
interest to determine whether these compounds also possessed
agonist activity at the 5-HT receptor mediating the reduction
in AHP amplitude. Administration of either of these corn-
pounds (30 tiM) failed to reduce the amplitude of the AHP
(mean reduction of the AHP amplitude by 2-methyl-5-HT,
1.1%, n = 5 cells; by phenylbiguanide, -2.6%, n = 5 cells)
whereas in these same cells 5-HT, at a comparable concentra-
tion, was an effective agonist. Phenylbiguanide and 2-methyl-
5-HT also failed to produce any consistent alteration in the
membrane potential of these cells.
5-MeOT has been reported to be equipotent with 5-HT at 5-
HT4 receptors whereas it is devoid of activity at 5-HT3 or
5HT1 receptors (Takaki et at., 1985; Dumuis et at., 1988a;
Hoyer and Neijt, 1988). Therefore, 5-MeOT was used in order
to further differentiate the receptor mediating the slow excita-
tory actions of 5-HT in the rat hippocampus from either 5-
HT3, 5-HT1 or 5-HT4 receptors. As illustrated in figure 3B,
bath administered 5-MeOT mimicked the actions of 5-HT in
reducing the AHP amplitude and in eliciting a membrane
depolarization. This compound appeared to have an intrinsic
activity comparable to that of 5-HT but was approximately one
order of magnitude less potent at eliciting these effects (fig. 3A,
n = 8 cells tested).
Effects of substituted benzamides. The above lines of
evidence suggest that the pharmacological profile of the recep-
tor under study closely approximates that of the proposed 5-
HT4 receptor. One of the distinguishing characteristics of this
receptor is its sensitivity to several 4-amino-5-chloro-2-meth-
oxy-substituted benzamides such as BRL 24924, zacopride and
cisapride (Dumuis et at., 1989a,b; Bockaert et at., 1990; Craig
and Clarke, 1990). Administration of either of these three
compounds (BRL 24924, 30 tiM, n = 8 cells; cisapride, 3 to 30
M, n = 6 cells; and zacopride, 30 M, n = 4 cells) markedly
reduced or blocked the effect of 5-HT on the AHP. As illus-
trated in figure 4, blockade of the effect of 5-HT by BRL 24924
was competitive and resulted in a rightward shift of the dose-
response curve for the 5-HT-induced reduction of the AHP.
Similar results were obtained with zacopride. In order to esti-
mate the potency of BRL 24924 and zacopride at this receptor,
we calculated pA2 values for their ability to reduce the effect of
5-HT. The mean pA2 for BRL 24924 was 5.3 ± 0.5 (mean ±
S.D., n = 5 cells) and for zacopride was 5.2 ± 0.6 (mean ± S.D.,
n = 4 cells). As illustrated in figure 5, cisapride also blocked
the effect of 5-HT and this effect was surmountable. However,
the slow time course of this blockade rendered impractical an
estimate of its potency. Nevertheless, the antagonism by cisa-
pride appeared to be selective as this compound failed to block











































Fig. 2. Effects of 5-CT on membrane potential and AHP amplitude. A, administration of nanomolar or low micromolar concentrations of 5-CT elicits
a concentration-dependent hyperpolarization. In the presence of BMY 7378 (10 M) to block 5-HT1A receptors, these same concentrations are
without effect on membrane potential or the amplitude of the AHP. However, increasing the concentration of 5-CT results in a reduction in the
amplitude of the AHP. At this concentration (1 0 M) 5-CT is capable of eliciting a small hyperpolarization even in the presence of BMY 7378.
However, this effect subsides more rapidly than the reduction in the AHP, thus revealing that 5-CT can reduce the AHP even in the absence of any
change in membrane potential (arrow). B, concentration-response curves for the 5-CT-induced hyperpolarization (#{149})and reduction in AHP amplitude
(V) obtained in a single neuron. C, concentration-response curve for the 5-HT-induced hyperpolarization (S) and reduction in AHP amplitude (V).
These two curves were also obtained in a single neuron and are illustrated here to provide a direct comparison to the effects of 5-CT. A and B, cell
membrane potential: -70 mV. C, membrane potential: -69 mV.
Fig. 3. Comparison of the effects of 5-HT
and 5-MeOT in a neuron of the CAl region.
A, 5-HT and 5-MoOT reduce the amplitude
of the AHP in a concentration-dependent
manner but 5-HT is about one order of
magnitude more potent. B, administration
of maximal concentrations of 5-HT and 5-
MeOT elicit depolarizations and reductions
in AHP amplitude of comparable magnitude
suggesting that both agonists exhibit com-
parable intrinsic activities. Break in the 5-
MeOT trace corresponds to 20 mm. A and
B were obtained from the same neuron. Cell
membrane potential, -59 mV;#{149},5-HT; V,
5-MeOT.
A, CONTROL 5-HT 1pM 5-HT 10pM 5-HT 3OpM
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Fig. 4. Blockade of the 5-HT-induced re-
5-HT 1 OOpM duction of the AHP by BAL 24924. A1, 5-
HT elicits a concentration-dependent re-
duction in the AHP amplitude. A2, BRL
24924 (30 M) antagonized this effect of 5-
HT and this blockade could be surmounted
by increasing the 5-HT concentration. In
this experiment 5-HT was administered
using the protocol illustrated in figure 1 A.
However, due to space considerations only
the AHPs are illustrated in this figure. A.,
superimposed AHPs in the presence and
absence of BRL 24924 illustrating that in
this cell this compound did not reduce the
AHP noticeably. C, concentration-response
relationship for the 5-HT reduction of the
AHP amplitude in the absence (I) and pres-
ence (V) of 30 M BRL 24924. Cell mem-







Fig. 5. Blockade of the effects of 5-HT by
cisapride. A, in this cell administration of 5-
HT (1 0 M) elicits a slow depolarization and
a 71 % reduction in the amplitude of the
AHP. B, administration of cisapride (30 zM)
by itself fails to elicit either a depolarization
or a decrease in the AHP. The small in-
crease in AHP amplitude observed in this
cell was not a consistent finding in these
experiments. C, after 50 mm in cisapnde
the effects of 10 zM 5-HT are greatly re-
duced. 0, administration of 100 M 5-HT,
however, is still capable of eliciting a reduc-
tion in AHP amplitude and a small depolar-







the reduction in AHP amplitude elicited by carbachol (n = 2
cells, not shown). In contrast to these results, bath adminis-
trated sulpiride (30 tM, n = 4), a substituted benzamide lacking
the 4-amino and 5-chloro substituents, failed to alter the effect
of 5-HT on the AHP or on membrane depolarization (not
shown).
Whereas all three substituted benzamides were capable of
blocking the effect of 5-HT, during the course of these experi-
ments it was observed that, in a small number of cells, these
compounds weakly mimicked the effect of 5-HT on the AHP
(fig. 6). This suggested that BRL 24924 might be a partial
agonist exhibiting very low intrinsic activity. If this were the
case, then it could be expected that the agonist activity of BRL
24924 should be most evident in cells exhibiting a high sensi-
tivity to 5-HT. In order to test this possibility we compared the
ability of 3 tM 5-HT and of 30 tM BRL 24924 to reduce the
AHP in a group of cells selected to include a disproportionate
number of cells exhibiting a high sensitivity to 5-HT. Thus,
the sample selected was not random but should be considered
as resulting from stratified sampling which overweighed for
those cells very sensitive to 5-HT. In this group almost all cells
(14/15) responded to 3 M 5-HT with a reduction in the AHP
amplitude, whereas only six cells responded to BRL 24924 with
a clear (10%) decrease (range, 11-22%). Although the sam-
pling protocol precluded an estimate of the proportion of cells
responsive to BRL 24924, it was still possible to compare the
sensitivity to 5-HT between BRL 24924 sensitive and insensi-
tive cells. Among these BRL 24924-responsive cells, the reduc-
tion in AHP amplitude elicited by 3 jM 5-HT averaged 46 ±
19.6% (mean ± S.D.) whereas that in the nonresponsive group
averaged 16 ± 10.4 %. This indicated a significantly (P = .002)
5-HT4-Like Receptors in Hippocampus
higher sensitivity to 5-HT among the BRL 24924-responsive
cells.
Discussion
Previous electrophysiological studies have detected slow ex-
citatory responses to 5-HT in the rat hippocampus. The recep-
tor mediating this response exhibits an atypical pharmacolog-
ical profile unlike that expected for the classical 5-HT1 or 5-
HT2 receptor subtypes but possessing some of the properties of
the 5-HT1, 5-HT3 and 5-HT4 subtypes (Andrade and Nicoll,
1987; Colino and Halliwell, 1987; Chaput et at., 1990). The
present results confirm and extent our previous suggestion that
this receptor does not belong to the 5-HT3 subtype (Chaput et
at., 1990) as 5-MeOT, but not of 2-methyl-5-HT or phenylbi-
guanide, mimicked the effects of 5-HT in reducing the AHP
and in eliciting a slow membrane depolarization. Moreover, the
present results also indicate that this receptor differs from the
5HT1 receptor but exhibits a pharmacological profile closely
resembling that of the 5-HT4 subtype. Thus, 5-MeOT, which
has been reported to be a full agonist at 5-HT4 receptors
(Dumuis et at., 1988a; Craig and Clarke, 1990), but to be without
effect at 5-HT1 receptors even when administered at concen-
trations 20 times higher than 5-HT (Takaki et at., 1985; Bran-
chek et at., 1988), was found to both reduce the AHP and to
induce a membrane depolarization. A similar differentiation
was also obtained by using 2-methyl-5-HT. This compound has
been reported to possess an affinity comparable to that of 5-
HT for 5-HT1 receptors (Branchek et at., 1988) where it
functions as an agonist (Mawe et at., 1986; Surprenant and
Crist, 1988), but to be approximately 1000-fold less potent than
5-HT at 5-HT4 receptors (Dumuis et at., 1988a; Craig and





Fig. 6. BRL 24924 is an agonist in a subset of neurons in the CAl region. A, in this cell administration of 5-CT (300 nM), a concentration that is
generally without effect on the AHP, elicits a long lasting reduction in the AHP amplitude. This effect is most evident upon recovery of the 5-HT1A
receptor-mediated hyperpolarization (arrow) and can be seen to subside gradually over time. In this same cell the subsequent administration of BRL
24924 (30 M) elicits a reduction in the amplitude of the AHP. Cell membrane potential, -61 mV. B, in a different cell administration of 30 MM 5-HT
reduces the AHP amplitude. Traces a, b and c corresponds to expanded traces illustrating the time course of the AHPs before, during and after 5-
HT. Subsequent administration of BRL 24924 to this same cell results in a reduction in the amplitude of the AHP. Traces d and e correspond to
expanded traces of the AHPs before and after BRL 24924. The reduction in the AHP is visualized most clearly upon superimpositions of traces d
and e (d + e). Cell membrane potential, -64 mV.
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Clarke, 1990). In the present study, 2-methyl-5-HT failed to
induce a depolarization or reduce the amplitude of the AHP,
even when administered at a concentration 30 times higher
than the threshold concentration for 5-HT. Together, these
results further differentiate this 5-HT receptor from the 5-
HT subtype, as defined in binding and functional assays in
the enteric nervous system, and strengthen its similarity to the
5-HT4 receptor.
One of the defining characteristics of the 5-HT4 receptor is
its affinity for several substituted benzamides, such as zaco-
pride, cisapride and BRL 24924 (Dumuis et at., 1989a,b; Bock.
aert et at., 1990; Craig and Clarke, 1990). In the present study
the 5-HT receptor mediating the depolarizing response and
decrease in the AHP could be blocked selectively by BRL 24924,
zacopride or cisapride and this effect was surmountable. It is
noteworthy that BRL 24924 and zacopride both exhibited pA2
values in the low micromolar range, which are in general
agreement with the potency of these compounds at 5-HT4
receptors in other systems (Bockaert et at., 1990; Craig and
Clarke, 1990). However it must be pointed out that the pA2
values presented here should be regarded as empirical measures
of their potency at this receptor (Kenakin, 1984) and further
work involving radioligand binding and Schild analysis will be
required to determine their affinity (Kd) for this site. Unfortu-
nately the poor water solubility and long time course of the
cisapride blockade made it impractical to estimate its potency.
However, qualitatively, it appeared at least as potent as BRL
24924 and zacopride. Thus, these compounds appeared to ex-
hibit potencies at the 5-HT receptor mediating the decrease in
the AHP well within the range of that reported previously for
5-HT4 receptors in either the adenylate cyclase or the guinea
pig ileum contraction assays.
The evidence outlined above suggests that the receptor medi-
ating the depolarization and decrease in the AHP in the hip-
pocampus exhibits a pharmacological profile similar to that of
the 5-HT4 receptor subtype. There are, however, some discrep-
ancies. First, in these experiments 5-MeOT exhibited an in-
trinsic activity comparable to that of 5-HT in reducing the
AHP amplitude, but was approximately one order of magnitude
less potent. This difference in potency, although similar to that
reported for 5-HT4 receptors mediating contraction in the
guinea pig ileum (Craig and Clarke, 1990), differs from that
reported for 5-HT4 receptors in cultured mouse embryo colli-
cular neurons in which 5-HT and 5-MeOT have been found to
be equipotent at stimulating adenylate cyclase (Dumuis et at.,
1988a). Second, whereas substituted benzamides blocked the
electrophysiological effects of 5-HT in most neurons tested in
this study, these same drugs have been reported to be full
agonists at 5-HT4 receptors potentiating the stimulus-induced
contraction of the guinea pig ileum (Craig and Clarke, 1990)
and in stimulating adenylate cyclase in cultured mouse colli-
cular neurons ((Dumuis et at., 1989a,b). Such a difference could
be interpreted as indicating that the receptor mediating the
depolarization and decrease in the AHP is similar but distinct
from the 5-HT4 subtype. However, BRL 24924 was found to
exhibit some agonist activity in a subpopulation of cells highly
sensitive to 5-HT, suggesting that these compounds might be
partial agonists possessing very low intrinsic activity in this
system. This possibility is consistent with the recent demon-
stration that 4-amino-5-chloro-2-methoxy-substituted benz-
amides function as partial agonists at hippocampal 5-HT4
receptors linked to the stimulation of adenylate cyclase (Bock-
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aert, 1990). Moreover, the use of intrinsic activity to classify
these receptors appear questionable, as intrinsic activity is
frequently dependent on the experimental preparation (Ken-
akin, 1984). For example, classical atpha and beta adrenoceptor
antagonists such as phentolamine and propranolol can function
as partial agonists in systems in which there is a very strong
coupling between the receptors and their respective effectors
(Hermsmeyer et at., 1982). Indeed, by using an electrophysio-
logical paradigm identical to that used in the present study we
have shown that BMY 7378, a partial 5-HT1A receptor agonist
in biochemical assays (Yocca et at., 1987), effectively antago-
nizes the 5-HT1A receptor-mediated hyperpolarizations of CA1
hippocampus pyramidal neurons (Chaput et at., 1990). Thus,
affinity rather than intrinsic activity may to be the better
criteria for classifying this receptor. Because the substituted
benzamides do exhibit significant affinity for the hippocampal
receptor mediating the reduction with AHP, from the results
outlined above, it appears that the most parsimonious classifi-
cation of this receptor would be as belonging to the 5-HT4
subtype.
5-HT administration reduced the AHP dose-dependently in
these cells in the range of 1 to 100 zM, a range similar to that
reported previously for the 5-HT-induced depolarization (An-
drade and Nicoll, 1987) and which overlaps with that of the 5-
HT1A receptor-mediated hyperpolarization. These results mdi-
cate that the 5-HT1A and 5-HT4 receptors present in hippocam-
pus operate in a similar concentration range. However, a de-
tailed comparison between the ability of 5-HT to reduce the
AHP and elicit the 5-HT1A response revealed that whereas its
potency at the 5HT1A receptor-mediated hyperpolarization was
extremely constant from cell to cell, there was considerably
variability in the potency of 5-HT to reduce the AHP. Although
the reason for this difference is presently unclear, it is possible
that the sensitivity of 5-HT4 receptors might be under active
regulation at the single cell level.
Biochemical studies have demonstrated that 5-HT1A and 5-
HT4 receptors are present in the guinea pig hippocampus where
both can regulate adenylate cyclase (Shenker et at., 1987; Du-
muis et at.,1988a,b). In these studies 5-CT was found to differ-
entiate between these receptors being much more potent at
5HT1A receptors than at those of the 5-HT4 subtype. A similar
differentiation by 5-CT between these two receptor was also
observed in the present study. This parallelism is striking
because the electrophysiological effects elicited by 5-HT1A
receptor activation have been shown to be independent of the
adenylate cyclase (Andrade et at., 1986) and it is unclear
whether cyclic nucleotides play any role in the signaling of the
electrophysiological responses elicited by 5-HT4 receptors. In
this regard it is noteworthy that previous electrophysiological
studies have shown that beta adrenergic and histamine H2
receptors act through adenylate cyclase (Madison and Nicoll,
1986) to produces electrophysiological effects identical to those
elicited by 5-HT4 receptor activation. However, the electro-
physiological response elicited by 5-HT4 receptor activation is
neither the result of beta adrenergic or H2 histaminergic recep-
tor activation by 5-HT or secondary to the release of endoge-
nous norepinephrine or histamine (Andrade and Nicoll, 1987).
A simple explanation for these results would be that 5-HT4
receptors directly stimulate adenylate cyclase in pyramidal
neurons and that this signals the electrophysiological response.
However, this simple interpretation has not been supported by
initial experiments (Andrade and Nicoll, 1987), pointing to the
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need for further work in order to establish the transduction
mechanism whereby 5-HT4 receptors signal their electrophys-
iological effects in this region.
Interestingly, 5-HT2 receptors have also been shown to elicit
depolarizing responses (North and Uchimura, 1989; Araneda
and Andrade, 1991) and to reduce the AHP (Araneda and
Andrade, 1991). Thus, 5-HT4 and 5-HT2 receptors appear to
signal similar electrophysiological responses although 5-HT2
receptors are known to couple to the inositol phospholipid
signaling mechanism (Conn and Sanders-Bush, 1985) whereas
5-HT4 receptors, at least in biochemical assays, stimulate aden-
ylate cyclase (Dumuis et al.,1988a; Bockaert et at., 1990).
Whereas further studies will be needed to determine the molec-
ular mechanism whereby this 5-HT4-like receptor signals its
electrophysiological responses in the hippocampus, this may
well represent a case in which two distinct receptors (the 5-
HT2 and the 5-HT4) converge through different molecular
mechanisms to elicit a common electrophysiological response.
In any case, the ability of this receptor to elicit a depolarization
and a decrease in the AHP indicate that activation of this
receptor is likely to signal slow excitatory responses to 5-HT.
Thus, the 5-HT4 receptor should be considered as part of the
growing number of 5-HT receptors mediating excitatory re-
sponses in central and peripheral neurons.
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